Big Pharma's Mixed Modes of Growth
Harvard Business Review
AUGUST 3, 2012
They might make a targeted acquisition here or there, form an alliance now and again, or license in some specialized technology, but by and large they made their own drugs, supporting big, fully staffed research labs, which they would then market themselves. Historically, big pharma firms made their own drugs.
Let's personalize your content